28. Sep 2020 |
5 min read
Dr. Grubb and his colleagues described SPS for the first time in an article in Scandinavian Journal of Clinical and Laboratory Investigation in 2015. In the AACC CLN Stat article To Catch Shrunken Pore Syndrome, Measure Cystatin C from July 2020, Dr. Grubb states that both cystatin C and creatinine are needed to diagnose SPS. Dr. Grubb therefore recommends to include the determination of cystatin C in the KDIGO guidelines which are from 2012, three years before SPS was discovered.
Since the launch of the webinar September 2019 more studies have been published regarding the novel shrunken pore syndrome (SPS):
Want to know more about Gentian’s Cystatin C Immunoassay? Watch this webinar with Gentian’s Product Manager for Cystatin C, Gaute Tangen.
For more details on cystatin C in general or the Gentian Cystatin C Immunoassay please contact us at email@example.com or fill out the form below:
Shrunken pore syndrome is now described on Wikipedia both in English and in Swedish:
Oct 14, 2020
We are looking forward to sharing news and exciting things that happened in the last few months. We have for..
Oct 06, 2020
#FAQ: Cystatin C In the third webinar of the cystatin C webinar series, Shanyil Wickramasinghe, Gentian’s US..
Sep 28, 2020
We hope you have had the chance to watch the successful AACC webinar The Use of Biomarkers in Chronic Kidney..